Clinical Trial Update: Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of monoclonal antibody 216 in combination with chemotherapy for adults with relapsed or refractory B-lineage acute lymphoblastic leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Monoclonal Antibody 216 (monoclonal antibody 216)

Snippet

Sponsor: Steven E. Coutre | Conditions: Leukemia, Lymphocytic, Leukemia | Phase 1 | Status: COMPLETED